This Webinar series explores the fundamental concept of big data in Medical Affairs, from which sources can we retrieve this, what are the broader considerations when utilizing data in health and what impact this can have on our organizations, physicians, and patients, now and in the future.
Medical congresses are crucial for keeping up with the latest life science industry standards and best practices – but planning is time-consuming and manual. What’s the alternative for better medical congress planning? Get the complete guide to congress planning.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Robin Winter-Sperry and Robert Kersting, PharmD, Global Head, Scientific Alliances, Novartis, about the need for multi-stakeholder partnerships.
This case study is useful for anyone working to anticipate market access issues and develop plans for launching new drugs in key markets.
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Jim Wilkinson, PhD, Vice President, Global & US Medical Affairs, Amgen, about how to develop Medical Affairs talent into tomorrow’s leaders.
In this webinar we will explore practical approaches to engaging patients in early development, introducing key resources and discussing best practices. These discussions will be tailored to meet the needs of all Medical Affairs colleagues, regardless of experience.
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
This presentation, part 3 of 3, provides insights into the types of communications that the FDA has indicated are or are not permissible, and the uncertainties that still remain.
By using the framework of Explore, Educate, Embrace we can shape our approach to Health Equity by incorporating it into our daily work.